Bharill Sonum, Lin Tyger, Arking Alexander, Brown Elizabeth A, West Margaret, Busin Kelly, Magge Sheela N, Wolf Risa M
Department of Pediatrics, Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Front Clin Diabetes Healthc. 2022 Sep 9;3:968113. doi: 10.3389/fcdhc.2022.968113. eCollection 2022.
The COVID-19 pandemic has disproportionately affected minority and lower socioeconomic populations, who also have higher rates of type 2 diabetes (T2D). The impact of virtual school, decreased activity level, and worsening food insecurity on pediatric T2D is unknown. The goal of this study was to evaluate weight trends and glycemic control in youth with existing T2D during the COVID-19 pandemic.
A retrospective study of youth <21 years of age diagnosed with T2D prior to March 11, 2020 was conducted at an academic pediatric diabetes center to compare glycemic control, weight, and BMI in the year prior to the COVID-19 pandemic (March 2019-2020) to during COVID-19 (March 2020-2021). Paired t-tests and linear mixed effects models were used to analyze changes during this period.
A total of 63 youth with T2D were included (median age 15.0 (IQR 14-16) years, 59% female, 74.6% black, 14.3% Hispanic, 77.8% with Medicaid insurance). Median duration of diabetes was 0.8 (IQR 0.2-2.0) years. There was no difference in weight or BMI from the pre-COVID-19 period compared to during COVID-19 (Weight: 101.5 v 102.9 kg, p=0.18; BMI: 36.0 v 36.1 kg/m2, p=0.72). Hemoglobin A1c significantly increased during COVID-19 (7.6% vs 8.6%, p=0.0002).
While hemoglobin A1c increased significantly in youth with T2D during the COVID-19 pandemic, there was no significant change in weight or BMI possibly due to glucosuria associated with hyperglycemia. Youth with T2D are at high risk for diabetes complications, and the worsening glycemic control in this population highlights the need to prioritize close follow-up and disease management to prevent further metabolic decompensation.
2019冠状病毒病(COVID-19)大流行对少数族裔和社会经济地位较低的人群产生了尤为严重的影响,而这些人群中2型糖尿病(T2D)的发病率也更高。虚拟学校、活动水平下降以及粮食不安全状况加剧对儿童T2D的影响尚不清楚。本研究的目的是评估COVID-19大流行期间患有T2D的青少年的体重趋势和血糖控制情况。
在一家学术性儿科糖尿病中心对2020年3月11日前被诊断为T2D的21岁以下青少年进行了一项回顾性研究,以比较COVID-19大流行前一年(2019年3月至2020年)和COVID-19期间(2020年3月至2021年)的血糖控制、体重和体重指数(BMI)。采用配对t检验和线性混合效应模型分析这一时期的变化。
共纳入63例患有T2D的青少年(中位年龄15.0(四分位间距14-16)岁,59%为女性,74.6%为黑人,14.3%为西班牙裔,77.8%有医疗补助保险)。糖尿病中位病程为0.8(四分位间距0.2-2.0)年。与COVID-19期间相比,COVID-19大流行前的体重或BMI没有差异(体重:101.5对102.9千克,p=0.18;BMI:36.0对36.1千克/平方米,p=0.72)。COVID-19期间糖化血红蛋白显著升高(7.6%对8.6%,p=0.0002)。
虽然在COVID-19大流行期间患有T2D的青少年糖化血红蛋白显著升高,但体重或BMI没有显著变化,这可能是由于高血糖相关的糖尿症所致。患有T2D的青少年发生糖尿病并发症的风险很高,这一人群血糖控制的恶化凸显了需要优先进行密切随访和疾病管理,以防止进一步的代谢失代偿。